PR Newswire AUCKLAND, New Zealand, Aug. 21, 2024 AUCKLAND, New Zealand, Aug. 21, 2024 /PRNewswire/ -- Headquartered in Auckland, New Zealand, Aroa Biosurgery is a global soft tissue reconstruction company which develops and manufactures ...
PR Newswire INDIANAPOLIS, Aug. 20, 2024 176-week SURMOUNT-1 Phase 3 study in adults with pre-diabetes is the longest completed trial of tirzepatide to date Tirzepatide resulted in sustained weight loss through the treatment period, ...
PR Newswire NEW YORK, Aug. 15, 2024 Early Detection of Type 1 Diabetes Can Help Reduce the Risk of Life-Threatening Complications at Diagnosis and Allow Time to Access Therapy that Can Delay the Onset of the Disease NEW YORK, Aug. 15, ...
PR Newswire ST. LOUIS, Aug. 13, 2024 Health clinicians are increasingly aware of the potential to put type 2 diabetes into remission through diet and other lifestyle interventions but too often lack the essential training to do it. ST. ...
SAN FRANCISCO and SUZHOU, China , July 21, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
SHENZHEN, China , July 19, 2024 /PRNewswire/ -- On July 19, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences") announced that it has received the Drug Registration Certificate approved and ...
- Largest prospective clinical study to date on placental tissue allografts - Collaboration with Mölnlycke ® Health Care ROSWELL, Ga. , July 18, 2024 /PRNewswire/ -- StimLabs ® , a leading regenerative medicine company, ...
EB-105 is the world's first pentavalent trispecific antibody targeting VEGF-A, VEGF-B, PlGF, Ang-2 and IL-6R in DME LOTUS study is the initial clinical trial of Eluminex's EB-105 being conducted in the United States SAN FRANCISCO ...
TORONTO , July 12, 2024 /CNW/ - Diabetes is one of the most common chronic diseases in Canada , affecting approximately 3.6 million people – and more than 200,000 new cases are diagnosed every year. The number of people living with ...
SAN ?WANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) -- Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza ® pre-filled pen, ...
Over 86% of Indians with diabetes suffer from mental health issues like anxiety and depression. ...
A diet high in formula and cereal during infancy may increase the risk of developing diabetes later in life. ...
People with diabetes need more than just stable blood sugar levels to stay healthy. Experts warn that excessive salt intake can significantly exacerbate diabetes complications and overall health risks. To mitigate these risks, individuals with ...
Neglecting timely diabetes management can lead to serious eye and brain complications, warn experts. A new study published in The Lancet revealed that about 212 million people lived with diabetes in India in 2022 -- the ...
Diabetes is a national health crisis affecting millions, necessitating a collaborative effort to curb its rising prevalence. Highlighting this year’s theme, “Breaking Barriers, Bridging Gaps,” at an event held in the national capital, ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers